Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Member of the German Center for Lung Research (DZL), Biomedical Research in End-stage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.
Clin Transplant. 2018 Apr;32(4):e13214. doi: 10.1111/ctr.13214. Epub 2018 Feb 23.
Non-adherence to immunosuppressive treatment following solid organ transplantation is common and often associated with poorer outcomes. Non-adherence is difficult to assess, and barriers to adherence in lung transplant (LTx) recipients remain to be elucidated.
A single-center cross-sectional observational study of all LTx recipients attending our department between 07/2013 and 05/2014 was performed. Non-adherence was assessed using patient self-reporting, including Basel Assessment of Adherence with Immunosuppressive Medication Scale (BAASIS) along with healthcare worker (HCW) judgment and reasons for non-adherence by the Immunosuppressive Therapy Barriers Scale.
A total of 138/504 patients (27.4%) self-reported non-adherence to immunosuppressive medication. HCW scored 96/504 patients (19.1%) as poorly adherent. Self-reported non-adherence increased with increasing interval after transplantation. The main reason for non-adherence was punctuality (75%), with only 11% reporting drug holidays. Explanations for non-adherence were primarily related to self-organization and difficulties incorporating medication into daily routine. There were no significant differences in medication knowledge or variation in trough levels.
This study confirms that non-adherence in LTx recipients is frequent according to self-report. Barriers are self-organization and difficulties incorporating medication into daily routine. Social and behavioral support is needed to overcome non-adherence. (ClinicalTrials.gov number: NCT01889017).
实体器官移植后免疫抑制治疗的不依从是常见的,且往往与较差的结果相关。不依从难以评估,肺移植(LTx)受者的依从性障碍仍有待阐明。
对 2013 年 7 月至 2014 年 5 月期间在我科就诊的所有 LTx 受者进行了一项单中心横断面观察性研究。不依从通过患者自我报告进行评估,包括巴塞尔评估免疫抑制药物依从性量表(BAASIS)以及医护人员(HCW)判断和免疫抑制治疗障碍量表的不依从原因。
共有 138/504 例(27.4%)患者自我报告免疫抑制药物不依从。HCW 将 96/504 例(19.1%)患者评为依从性差。自我报告的不依从随着移植后时间间隔的增加而增加。不依从的主要原因是准时性(75%),只有 11%的患者报告了药物假期。不依从的解释主要与自我组织和将药物纳入日常生活困难有关。药物知识没有显著差异,也没有药物浓度波动。
这项研究证实,根据自我报告,LTx 受者的不依从是常见的。障碍是自我组织和将药物纳入日常生活困难。需要社会和行为支持来克服不依从。(临床试验编号:NCT01889017)。